Search Results for "Depo-testosterone"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Depo-testosterone. Results 1 to 4 of 4 total matches.
See also: testosterone
In Brief: Azmiro — A Single-Dose Injectable Formulation of Testosterone Cypionate
The Medical Letter on Drugs and Therapeutics • Mar 17, 2025 (Issue 1724)
IM q2-4 weeks $65.70
Depo-Testosterone (Pfizer) 138.20
Azmiro (Azurity) 1 mL single-dose vials ...
The FDA has approved Azmiro (Azurity), the first
injectable formulation of testosterone cypionate to
become available in single-dose vials and prefilled
syringes for treatment of males with conditions
associated with a deficiency or absence of endogenous
testosterone. Injectable testosterone cypionate has
been available in multidose vials (Depo-Testosterone,
and generics) for many years. Testosterone enanthate
(Xyosted) is available in prefilled autoinjectors for use
in adult men. No testosterone products are approved
for treatment of low testosterone levels due solely
to aging. All...
Med Lett Drugs Ther. 2025 Mar 17;67(1724):44-5 doi:10.58347/tml.2025.1724b | Show Introduction Hide Introduction
Two New Oral Testosterone Products for Hypogonadism
The Medical Letter on Drugs and Therapeutics • Oct 31, 2022 (Issue 1662)
cypionate – generic 1, 10 mL vials (100, 200 mg/mL)4,5 50-400 mg IM q2-4 weeks $58.10
Depo-Testosterone ...
The FDA has approved two new oral formulations
of testosterone undecanoate — Kyzatrex (Marius)
and Tlando (Antares) — for treatment of males
with a deficiency of endogenous testosterone
due to conditions such as Klinefelter syndrome,
orchiectomy, toxic damage from chemotherapy or
alcohol, or pituitary-hypothalamic injury caused
by tumors, trauma, or radiation. Jatenzo, another
oral testosterone undecanoate formulation, was
approved for the same indication in 2019. No
testosterone products are approved for treatment of
low testosterone levels due solely to...
Jatenzo - An Oral Testosterone for Hypogonadism
The Medical Letter on Drugs and Therapeutics • Jun 28, 2021 (Issue 1627)
cypionate – generic 1, 10 mL vials (100, 200 mg/mL)4,5 50-400 mg IM q2-4 weeks $74.90
Depo-Testosterone ...
An oral formulation of testosterone undecanoate
(Jatenzo – Clarus) has been approved by the FDA for
treatment of adult men with conditions associated
with a deficiency of endogenous testosterone, such as
Klinefelter syndrome, orchiectomy, toxic damage from
chemotherapy or alcohol, or pituitary-hypothalamic
injury from tumors, trauma, or radiation. Jatenzo is
not approved for treatment of low testosterone levels
solely due to aging. It is the first oral testosterone
formulation to be approved in the US.
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • May 15, 2023 (Issue 1676)
acetate)
Depo-SubQ Provera 104 4% 0.2%
Depo-Provera
Injected once every ~3 months;
decreased risk ...
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also effective in
preventing pregnancy. When used alone, barrier and
behavioral methods generally have higher failure
rates than other methods (see Table 1). Selection of
a contraceptive method is usually based on patient-specific factors and personal preference
Med Lett Drugs Ther. 2023 May 15;65(1676):73-80 doi:10.58347/tml.2023.1676a | Show Introduction Hide Introduction